Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 05-2021 | 03-2021 | 02-2021 | 11-2020 | |
| Sales | 674 | 681 | 666 | 665 | 674 |
| Gross Profit | 674 | 681 | 666 | 665 | 674 |
| Operating Expenses | 5,124 | 6,799 | 7,270 | 5,533 | 6,501 |
| Operating Income | -4,450 | -6,118 | -6,604 | -4,868 | -5,827 |
| Interest Expense | 0 | -493 | 0 | 0 | 12 |
| Other Income | 541 | 0 | 541 | 260 | 269 |
| Pre-tax Income | -3,909 | -5,625 | -6,063 | -4,608 | -5,570 |
| Net Income Continuous | -3,909 | -5,625 | -6,063 | -4,608 | -5,570 |
| Minority Interests | -92 | -418 | -393 | N/A | N/A |
| Net Income | $-3,817 | $-5,207 | $-5,670 | $-4,608 | $-5,570 |
| EPS Basic Total Ops | -0.12 | -0.17 | -0.20 | -0.17 | -0.23 |
| EPS Basic Continuous Ops | -0.13 | -0.19 | -0.22 | -0.17 | -0.23 |
| EPS Diluted Total Ops | -0.12 | -0.17 | -0.20 | -0.17 | -0.23 |
| EPS Diluted Continuous Ops | -0.13 | -0.19 | -0.22 | -0.17 | -0.23 |
| EBITDA(a) | $-4,404 | $-6,088 | $-6,592 | $-4,856 | $-5,825 |